RXRX Recursion Pharmaceuticals In

held by 1 manager in Q4 2021

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.16%	6 mo	—	$4M	259,941

Search